|
|
||||||||
American Journal of Clinical Nutrition, Vol 45, 687-692, Copyright © 1987 by The American Society for Clinical Nutrition, Inc
ORIGINAL RESEARCH COMMUNICATIONS |
JA Olson
Vitamin K is essential for the formation of at least three proteins involved in blood clotting as well as of other proteins found in plasma, bone, and kidney. Vitamin K deficiency, however, primarily affects the blood clotting process. Vitamin K is provided both from the diet and from endogenous bacterial synthesis, presumably in roughly equal measure. Because intakes of 0.4 micrograms X kg-1 X d-1 (0.89 nmol X kg-1 X d-1) and probably lower intakes maintain normal clotting activities in healthy neomycin-treated adults, rounded daily recommended dietary intakes (RDI) for essentially all reference 76-kg men and 62-kg women are 45 micrograms (100 nmol) and 35 micrograms (78 nmol) phylloquinone, respectively. Newborn infants are at high risk because breast milk contains inadequate concentrations of vitamin K and their intestines are not yet colonized with vitamin K-producing bacteria. Body reserves of vitamin K are small and turnover rapidly. Hence, supplementation of infants with vitamin K is highly advisable. Increments of vitamin K during pregnancy and lactation are also suggested.
This article has been cited by other articles:
![]() |
J. R Kuykendall, M. D Houle, and R. S Rhodes Possible Warfarin Failure Due to Interaction with Smokeless Tobacco Ann. Pharmacother., April 1, 2004; 38(4): 595 - 597. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Pettei, D. Israel, and J. Levine Serum Vitamin K Concentration in Pediatric Patients Receiving Total Parenteral Nutrition JPEN J Parenter Enteral Nutr, September 1, 1993; 17(5): 465 - 467. [Abstract] [PDF] |
||||
![]() |
J. B. Alperin Coagulopathy Caused by Vitamin K Deficiency in Critically III, Hospitalized Patients JAMA, October 9, 1987; 258(14): 1916 - 1919. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |